February 24, 2017 | Story Review

Philadelphia Inquirer is clear about the underwhelming benefits of testosterone therapy in older men

This story makes it clear that knowledge about many of the potential benefits of testosterone is still in flux, and other claims just don’t bear up under the weight of scientific scrutiny.

5 Star

Major study finds testosterone therapy is no fountain of youth

February 23, 2017 | Story Review

HealthDay’s story on stem cells for aggressive MS is upfront about death risk

But the story would have been stronger if it had made it clearer that this was not an experimental trial.

3 Star

Stem Cell Transplants May Help Some With Multiple Sclerosis

February 22, 2017 | Story Review

TIME is upfront about new psoriasis drug’s black box warning for suicidal behavior risk

Given the suicide risk, news stories ideally emphasize that it remains unclear how this new treatment will compare in terms of effectiveness and safety to existing medicines.

4 Star

How a New Psoriasis Drug Is Different From Others

February 22, 2017 | News Release Review

PR release touts big numbers in HRT protection against dementia studies, but ignores important numbers

The seemingly massive study size of the studies summarized here overshadow the minimal effects from hormone therapy.

2 Star

Postmenopausal hormone therapy exceeding ten years may protect from dementia


Tips for Understanding Studies

View More


Story Reviews

Our team of reviewers applies 10 standardized criteria to news stories that include claims about health care interventions. ~2,000 reviews published.

Read More

News Release Reviews

We systematically evaluate the quality of health care-related news releases by journals, medical centers, drug/device makers, others.

Read More


Wide-ranging exploration of issues in journalism, journal publishing, health care PR, advertising and marketing. Some opinions - publisher Gary Schwitzer's & others'.

Read More